final lecture 8 Flashcards
PT reflects
extrinsic pathway
aPTT reflects
intrinsic pathway
INR reflects
factors II, VII, X
heparin treatment dosing
initiation: 8units/kg bolus
followed by infusion: 18 units/kg/h
heparin monitoring
aPTT 1.5-2.5
major bleeding w/ heparin
when 2g decrease in Hgb
heparin antidote
1 mg protamine sulfate will neutralize 100 units of heparin
enoxaparin therapeutic dose
1mg/kg Q12H
dalteparin therapeutic dose
200 units/kg Q24H
LMWH monitoring
CBC
fondaparinux doses
100kg: 10mg QD
at what time of day should you give warfarin?
at bedtime
warfarin dose
5-10mg if 65
need UFH or LMWH to ____
bridge until patient reaches therapeutic range w/ warfarin
time to steady state on warfarin
8-15 days
warfarin monitoring
INR 2-3
mechanical valves 2.5-3.5
warfarin adustment is based on
weekly dose
adjust by 5-10% based on INR
ADRs for warfarin
skin necrosis
purple toe syndrome
teratogenic
drug interactions w/ warfarin
bactrim, amiodarone, metronidazole, azoles, rifampin, barbiturates, vitamin K, EtOH,
supratherapeutic warfarin 4.5<10
vitamin K generally not recommended; skip 1-2 doses
supratherapeutic warfarin INR>10, no sig. bleeding
give vit K(2.5-5mg PO)
supratherapeutic warfarin serious bleeding at any INR elecation
give vit K (5-10 slow IV)
supratherapeutic warfarin life-threatening bleed
hold warfarin; given frozen plasma
rivaroxaban dose
factor Xa inhibitor
VTE: 15mg PO BID X 3 weeks, then 20mg PO QD for 3 months
Afib: 20mg PO QD
rivaroxaban pros
no monitoring, less interactions
apixaban dose
factor Xa inhibitor
VTE/PE: 10mg PO BID X7 days then 5mg PO BID for 6 montsh then 2.5mg BID x 12month
Afib: 5mg BID
dabigatran dose
IIa(thrombin) inhibitor (DTI)
Afib/VTE/PE: 150mg PO BID